Sep 18, 2014

A Conference on Post-Trial Responsibilities: Ethics and Implementation

MRCT Center at Harvard and the Petrie-Flom Center at Harvard Law School co-host A Conference on Post-Trial Responsibilities: Ethics and Implementation.

Introduction / Background:

The term “post-trial access” is used broadly to connote a wide range of possibilities for providing continued access to study interventions (and potentially other care) once a trial is over, or a subject’s participation has ended. For the purposes of this conference, we will focus discussions on the following:

Continued access to study intervention(s) and/or other care for people who were enrolled in the clinical trial and were benefitting (whether between the end of the trial and product approval or indefinitely)

Provision of the study intervention(s) and/or other care to people who were enrolled in the clinical trial but did not get the intervention and would like to try it (whether between the end of the trial and product approval or indefinitely)

Provision of the study intervention, other care, or other resources to the community in which the trial was conducted